Y chromosome loss in cancer drives growth by evasion of adaptive immunity (vol <bold>626, </bold>E11, 2024)

被引:0
|
作者
Abdel-Hafiz, Hany A.
Schafer, Johanna M.
Chen, Xingyu
Xiao, Tong
Gauntner, Timothy D.
Li, Zihai
Theodorescu, Dan
机构
[1] Cedars–Sinai Medical Center,Department of Urology
[2] The Ohio State University Comprehensive Cancer Center–The James,Pelotonia Institute for Immuno
[3] Cedars-Sinai Medical Center,Oncology
[4] Cedars-Sinai Cancer Center,Department of Pathology and Laboratory Medicine
[5] Roche Diagnostics Solutions,undefined
关键词
D O I
10.1038/s41586-024-07104-w
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
引用
收藏
页码:E11 / E11
页数:1
相关论文
共 7 条
  • [1] Y chromosome loss in cancer drives growth by evasion of adaptive immunity
    Hany A. Abdel-Hafiz
    Johanna M. Schafer
    Xingyu Chen
    Tong Xiao
    Timothy D. Gauntner
    Zihai Li
    Dan Theodorescu
    Nature, 2023, 619 : 624 - 631
  • [3] Y chromosome loss in cancer drives growth by evasion of adaptive immunity
    Abdel-Hafiz, Hany A.
    Schafer, Johanna M.
    Chen, Xingyu
    Xiao, Tong
    Gauntner, Timothy D.
    Li, Zihai
    Theodorescu, Dan
    JOURNAL OF UROLOGY, 2024, 211 (02): : 624 - +
  • [4] Author Correction: Y chromosome loss in cancer drives growth by evasion of adaptive immunity
    Hany A. Abdel-Hafiz
    Johanna M. Schafer
    Xingyu Chen
    Tong Xiao
    Timothy D. Gauntner
    Zihai Li
    Dan Theodorescu
    Nature, 2024, 626 : E11 - E11
  • [5] Polθ is phosphorylated by PLK1 to repair double-strand breaks in mitosis (vol <bold>626, </bold>E13, 2024)
    Gelot, Camille
    Kovacs, Marton Tibor
    Miron, Simona
    Mylne, Emilie
    Haan, Alexis
    Boeffard-Dosierre, Liza
    Ghouil, Rania
    Popova, Tatiana
    Dingli, Florent
    Loew, Damarys
    Guirouilh-Barbat, Josee
    Del Nery, Elaine
    Zinn-Justin, Sophie
    Ceccaldi, Raphael
    NATURE, 2024, 626 (7999) : E13 - E13
  • [6] Y CHROMOSOME LOSS DRIVES BLADDER CANCER AGGRESSIVENESS AND IMMUNE EVASION
    Abdel-Hafiz, H. A.
    Schafer, J. M.
    Chen, X.
    Xiao, T.
    Gauntner, T. D.
    Li, Z.
    CANCER DISCOVERY, 2023, 13 (08) : 1761 - 1761
  • [7] Nemvaleukin alfa, a novel engineered IL-2 fusion protein, drives antitumor immunity and inhibits tumor growth in small cell lung cancer (vol 10, e004913, 2022)
    Pan, Y.
    Hao, Y.
    Han, H.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (11)